Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Device of Tomorrow Capital is an early-stage investment fund established to focus on the medical technology sector. Founded in Irvine, California, the firm is dedicated to identifying and supporting entrepreneurs who are driving significant transformations in healthcare. The organization operates with a clear mission to ensure that groundbreaking solutions reach the market, thereby enhancing patient care and medical practices.
Currently, Device of Tomorrow Capital manages a portfolio of eight companies, reflecting its commitment to fostering innovation in healthcare. The firm primarily invests in the United States and has a strong emphasis on sectors such as artificial intelligence, robotics, and biotechnology. Their approach combines financial backing with strategic support to help startups navigate the complexities of the medical technology landscape.
Device of Tomorrow Capital invests in breakthrough innovations within the medical technology field, particularly in the United States. The firm targets early-stage investments, specifically in pre-seed, seed, and Series A rounds. Their investment strategy emphasizes sectors such as healthcare, artificial intelligence, biotechnology, and robotics, which are pivotal in reshaping the future of medical practices.
The organization seeks to partner with entrepreneurs who are developing advanced technologies that can significantly impact patient outcomes and healthcare delivery. Device of Tomorrow Capital looks for teams that demonstrate a strong vision, technical expertise, and a commitment to innovation. They prefer to engage in deals that allow for collaborative growth and often consider co-investment opportunities to maximize their impact.
Device of Tomorrow Capital's portfolio includes eight notable companies that exemplify their focus on medical technology:
These companies represent a diverse range of solutions aimed at improving healthcare outcomes through technology. Each portfolio company is positioned to make a significant impact in their respective fields, aligning with Device of Tomorrow Capital's mission to drive innovation in medical technology.
Henry Yan: Managing Partner at Device of Tomorrow Capital. Henry has a background in venture capital and has led numerous investments in the healthcare sector. His expertise lies in identifying transformative technologies and supporting entrepreneurs in the medical technology space.
To pitch Device of Tomorrow Capital, founders should send an email to henry.yan@luminor.us. It is recommended to include a comprehensive pitch deck that outlines the startup's vision, technology, and market opportunity. Response times may vary, but founders can expect to hear back within a few weeks.
What investment criteria does Device of Tomorrow Capital use?
Device of Tomorrow Capital focuses on early-stage investments in the medical technology sector, particularly in companies that are developing breakthrough innovations in artificial intelligence, robotics, and biotechnology. They look for strong founding teams with a clear vision and the potential to transform healthcare.
How can I pitch to Device of Tomorrow Capital?
Founders can reach out via email at henry.yan@luminor.us. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and technology involved.
What makes Device of Tomorrow Capital different from other investors?
The firm specializes exclusively in medical technology, providing not only capital but also strategic support to help startups navigate the healthcare landscape. Their focus on breakthrough innovations sets them apart from generalist investors.
What is the geographic focus of Device of Tomorrow Capital?
Device of Tomorrow Capital primarily invests in companies based in the United States, emphasizing innovations that can significantly impact the local healthcare system.
What is the typical check size for investments?
While specific check sizes are not disclosed, Device of Tomorrow Capital typically invests in pre-seed, seed, and Series A rounds, which generally range from hundreds of thousands to several million dollars.
What kind of post-investment support does Device of Tomorrow Capital provide?
The firm actively engages with its portfolio companies, offering mentorship, operational support, and access to a network of industry experts to help drive growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.